Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference30 articles.
1. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast-cancer — high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study;Gianni;J. Clin. Oncol.,1995
2. The taxanes: an update;Crown;Lancet,2000
3. Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer;Vasey;J. Clin. Oncol.,1999
4. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers;Pegram;Oncogene,1999
5. Recombinant humanized anti-HER2 antibody (herceptin (TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Res.,1998
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Studies on polyethylene glycol crosslinked chitosan nanoparticles for co-delivery of docetaxel and 5-fluorouracil with synergistic effect against cancer;Macromolecular Research;2024-01-10
2. Fabrication, in-silico, in-vitro, and in-vivo characterization of transferrin-targeted micelles containing cisplatin and gadolinium for improved theranostic applications in lung cancer therapy;European Journal of Pharmaceutics and Biopharmaceutics;2023-12
3. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy;Journal of Controlled Release;2023-09
4. Biomedical,clinical and environmental applications of platinum-based nanohybrids: An updated review;Environmental Research;2023-08
5. Drug‐Eluting Porous Embolic Microspheres for Trans‐Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer;Advanced Healthcare Materials;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3